Catalyst Wire Dossier Catalyst Wire Dossier

Zirconium-89-girentuximab

girentuximab
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zirconium-89-girentuximab, covering 2017-06-19 to 2017-06-19. Get the full timeline:

Most recent: Clinical Trial Update: Zirconium-89-girentuximab PET/CT Imaging in Renal Cell Carcinoma [Phase 2, Phase 3]

See pricing